A combination of subcutaneous interleukin-2 and recombinant interferon alfa in the treatment of advanced renal cell carcinoma and melanoma.

M. Vuoristo; I. Jantunen; S. Pyrhönen; T. Muhonen; P Kellokumpu-Lehtinen

A combination of subcutaneous interleukin-2 and recombinant interferon alfa in the treatment of advanced renal cell carcinoma and melanoma.

M. Vuoristo, I. Jantunen, S. Pyrhönen, T. Muhonen, P Kellokumpu-Lehtinen

Research output: Contribution to journal › Article › Scientific › peer-review

18 Citations (Scopus)

Original language	English
Pages (from-to)	530-532
Journal	EUR J CANCER
Volume	30
Publication status	Published - 1994
Externally published	Yes
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{d50669be30744818a279e0933af08f14,

title = "A combination of subcutaneous interleukin-2 and recombinant interferon alfa in the treatment of advanced renal cell carcinoma and melanoma.",

author = "M. Vuoristo and I. Jantunen and S. Pyrh{\"o}nen and T. Muhonen and P Kellokumpu-Lehtinen",

year = "1994",

language = "English",

volume = "30",

pages = "530--532",

}

TY - JOUR

T1 - A combination of subcutaneous interleukin-2 and recombinant interferon alfa in the treatment of advanced renal cell carcinoma and melanoma.

AU - Vuoristo, M.

AU - Jantunen, I.

AU - Pyrhönen, S.

AU - Muhonen, T.

AU - Kellokumpu-Lehtinen, P

PY - 1994

Y1 - 1994

M3 - Article

SN - 0959-8049

VL - 30

SP - 530

EP - 532

JO - EUR J CANCER

JF - EUR J CANCER

ER -